Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia?
OBJECTIVES: To establish whether local practice review and national methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines have increased the survival of patients with MRSA bacteraemia. METHODS: A multisite retrospective analysis of survival of patients with MRSA bacteraemia, which included patients from March 1995 to December 2008. Periods before and after the publication of UK guidelines were compared. RESULTS: Data were analysed for 1675 patients with a mean age of 69.8 years. Survival for the period up to and including 2003 was 64.3%, and was 62.8% for both 2004-2005 and 2006-2008. CONCLUSIONS: No significant difference in survival in relation to local practice review or the publication of national guidelines was detected.
Related Questions
- If I have had a methicillin-resistant Staphylococcus aureus (MRSA) infection or been told that I carry MRSA, am I at high risk for developing a serious MRSA infection if I get seasonal influenza?
- What role, if any, does Keflex have in the treatment of methicillin-resistant Staphylococcus aureus (MRSA), particularly community-acquired MRSA?
- Where is MRSA found and how is it spread?
